Biosimilar developers should expect case-by-case evaluations, as the draft offers no hard rules on when CES will be waived. Developers are encouraged to consult the FDA early to understand evidentiary ...
AI is not merely a computational tool but an organizational change agent. Its ability to gather and analyze real-time data ...
Introduction In October 2025, the International Institute for the Middle East and Balkan Studies (IFIMES) in Ljubljana ...
Sometimes, we even find a way to spin new information in ways that will support that belief rather than change our minds.
Aiming to investigate small island resilience in public health emergencies, we found existing classifications of Small Island ...
New York, NY, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Following a challenge from the American Forest & Paper Association (AF&PA), BBB National Programs’ National Advertising Division recommended that Plant ...
There is no evidence that less frequent financial reporting impairs company performance, market functioning, or the quality of investor information.
The U.S. Food and Drug Administration (FDA) announced on Wednesday that it will be making it easier to develop biosimilar ...
Extending presidential terms would undermine Ghana's democratic gains, potentially eroding trust in institutions. Public ...
UCL scientists found that human skulls evolved much faster than those of other apes, reflecting the powerful forces driving ...
The rushed and uneven rollout of A.I. has created a fog in which it is tempting to conclude that there is nothing to see here ...
Logistics emerges as a core theme at ADIPEC 2025, where eight leading companies demonstrate the systems powering regional and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback